RemedyRepack Inc. is recalling 40 vials of Ketorolac Tromethamine (30 mg/mL) Injection due to the presence of visible particles identified as crystalline ketorolac calcium salt. This injectable medication, which is the generic version of Toradol, was repackaged from a manufacturer's lot that was also recalled for this defect. Consumers should not use the affected vials as injecting particles into the bloodstream can cause serious health complications. This product was distributed to a single location in Louisiana.
The presence of crystalline particles in an injectable drug can cause local irritation, swelling, or more serious issues like the blockage of blood vessels, which could lead to a stroke, heart attack, or damage to other organs.
Manufacturer refund/return protocol.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.